Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ORION PHARMA AS
AS
Active
Org 967727970
Sandakerveien 130, 0484
Oslo
Activities of agents involved in the wholesale of other particular products
·
NACE 4618
Est. 1993 · 32 years old
13 employees
www.orionpharma.no
Overvåg
Share
Norway
/
Companies
/
Activities of agents involved in the wholesale of other particular products
/
ORION PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
15M
30M
46M
61M
36M
2021
46M
2022
49M
2023
53M
2024
51M
2025
EBITDA
NOK millions
11M
8M
6M
3M
0M
2M
2021
9M
+350%
2022
5M
-44%
2023
9M
+80%
2024
8M
-11%
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
35 898
45 856
48 686
52 773
50 650
Staff expenses
−22 633
−22 307
−23 261
−22 759
−21 268
EBITDA
1 866
9 121
5 176
9 498
7 924
Depreciation & amort.
−44
−44
−44
−44
−44
EBIT
1 823
9 077
5 132
9 454
7 881
Net financials
4
90
440
452
499
Profit before tax
1 827
9 167
5 572
9 906
8 379
Tax
422
2 047
1 241
2 186
1 860
Net profit
1 405
7 119
4 331
7 720
6 520
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
14 563
22 963
26 063
22 554
22 907
Equity
4 815
9 934
4 265
4 984
3 104
Long-term debt
17
16
13
9
0
Short-term debt
9 731
13 014
21 786
17 561
19 800
Total debt
9 748
13 029
21 799
17 570
19 803
Financial ratios
5-year trend
EBITDA-margin
15.6%
This company
15.8%
Market median
+1% vs market
2021
2025
Soliditetsgrad
13.5%
This company
38.2%
Market median
-65% vs market
2021
2025
Egenkapitalforrentning
210.0%
This company
18.4%
Market median
+1041% vs market
2021
2025
Nettoresultatgrad
12.9%
This company
8.1%
Market median
+59% vs market
2021
2025
Aktivomsætning
2.21×
This company
1.12×
Market median
+97% vs market
2021
2025
Gæld/egenkapital
6.38×
This company
0.62×
Market median
-929% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on ORION PHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
